Every record from Janoshik · page 42
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020246 | BPC-157 | GGPeps | GGPE-2502-U2458 | 2025-Q3 | 99.34 | 5.08 | 100.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019785 | Selank | HJ | HJ-2507-F3983 | 2025-Q3 | 99.14 | 8.98 | 94.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019237 | NAD+ | TFC | TFC-2505-C6056 | 2025-Q3 | 99.36 | 12.19 | 97.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-021153 | TB-500 | WXT | WXT-2502-A5571 | 2025-Q3 | 97.85 | 2.47 | 91.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-019911 | Thymosin α1 | SWB | SWB-2503-S5672 | 2025-Q3 | 99.36 | 3.17 | 99.8 | Supplier-supplied | 0 | PASS |
| AX-2025-019430 | Semaglutide | Homopeptide | HOMO-2506-V8763 | 2025-Q3 | 99.21 | 4.39 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019373 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 98.44 | 4.42 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018871 | TB-500 | QSC | QSC-2505-B8934 | 2025-Q3 | 99.93 | 4.84 | 98.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019725 | PEG-MGF | HJ | HJ-2507-S2872 | 2025-Q3 | 97.51 | 6.80 | 102.8 | Supplier-supplied | 0 | PASS |
| AX-2025-019185 | Tirzepatide | TFC | TFC-2507-T5380 | 2025-Q3 | 98.04 | 4.42 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021051 | Semaglutide | WXT | WXT-2508-G4316 | 2025-Q3 | 98.72 | 2.68 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020998 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 96.50 | 3.75 | 96.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020759 | BPC-157 | SGN | SGN-2507-F9952 | 2025-Q3 | 98.60 | 4.58 | 95.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019904 | Thymosin α1 | SWB | SWB-2503-S5672 | 2025-Q3 | 99.10 | 2.90 | 96.3 | Laboratory-retained | 0 | PASS |
| AX-2025-019736 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 98.91 | 6.29 | 105.7 | Buyer-sourced | 0 | FAIL |
| AX-2025-019370 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 98.68 | 5.18 | 96.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019142 | PEG-MGF | TFC | TFC-2507-M4201 | 2025-Q3 | 98.04 | 3.90 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021238 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.98 | 6.01 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020622 | BPC-157 | SSA | SSA-2505-J7223 | 2025-Q3 | 98.71 | 3.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020360 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.25 | 7.39 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020293 | 5-Amino-1MQ | MKM | MKM-2503-H2930 | 2025-Q3 | 99.41 | 4.70 | 100.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-019693 | Semaglutide | HJ | HJ-2507-E3085 | 2025-Q3 | 99.83 | 5.63 | 90.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019434 | Semaglutide | Homopeptide | HOMO-2506-V8763 | 2025-Q3 | 98.77 | 5.37 | 103.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019321 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 97.81 | 3.66 | 103.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018876 | TB-500 | QSC | QSC-2505-B8934 | 2025-Q3 | 99.55 | 4.92 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020888 | Thymosin α1 | CPC | CPC-2504-M1855 | 2025-Q3 | 97.83 | 5.33 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020553 | L-Glutathione (reduced) | SSA | SSA-2506-X6030 | 2025-Q3 | 98.99 | 8.53 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019374 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 98.84 | 4.69 | 94.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018694 | Retatrutide | QSC | QSC-2502-D6580 | 2025-Q3 | 98.33 | 6.61 | 92.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018502 | MOTS-c | WWB | WWB-2505-G2801 | 2025-Q3 | 99.83 | 2.36 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020623 | BPC-157 | SSA | SSA-2505-J7223 | 2025-Q3 | 99.27 | 3.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019757 | Semaglutide | HJ | HJ-2507-Y3362 | 2025-Q3 | 98.80 | 3.69 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019469 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 98.57 | 6.24 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018879 | Retatrutide | QSC | QSC-2504-R9199 | 2025-Q3 | 98.63 | 2.24 | 99.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018692 | Survodutide | QYB | QYB-2502-G6252 | 2025-Q3 | 99.06 | 6.19 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021055 | Sermorelin | WXT | WXT-2506-D4780 | 2025-Q3 | 98.01 | 6.42 | 92.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020997 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 97.44 | 3.24 | 106.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020989 | Enclomiphene citrate | CPC | CPC-2505-Y3713 | 2025-Q3 | 97.91 | 5.72 | 90.9 | Supplier-supplied | 2 | FAIL |
| AX-2025-020024 | Ipamorelin | ERP | ERP-2502-S7254 | 2025-Q3 | 99.21 | 3.89 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019598 | TB-500 | Homopeptide | HOMO-2504-G1782 | 2025-Q3 | 99.52 | 4.38 | — | Supplier-supplied | 2 | MARGINAL |